The global Epilepsy Therapeutic market was valued at US$ 4076.9 million in 2023 and is anticipated to reach US$ 5227.3 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Epilepsy Therapeutic Market

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.

In terms of geography, the Americas led the global epilepsy therapeutic market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.

This report aims to provide a comprehensive presentation of the global market for Epilepsy Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epilepsy Therapeutic.

Report Scope

The Epilepsy Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epilepsy Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Epilepsy Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Epilepsy Therapeutic Market Report

Report Metric	Details
Report Name	Epilepsy Therapeutic Market
Accounted market size in 2023	US$ 4076.9 million
Forecasted market size in 2030	US$ 5227.3 million
CAGR	3.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	First Generation Second Generation
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, GlaxoSmithKline Plc, UCB, Cephalon, Johnson & Johnson, Pfizer, Novartis AG, Abbvie, Janssen Pharmaceuticals, Sunovion Pharmaceuticals, Bausch Health, Sanofi S.A, Takeda, Eisai, F. Hoffmann-La Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epilepsy Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Epilepsy Therapeutic Market growing?

Ans: The Epilepsy Therapeutic Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Epilepsy Therapeutic Market size in 2030?

Ans: The Epilepsy Therapeutic Market size in 2030 will be US$ 5227.3 million.

What is the Epilepsy Therapeutic Market share by region?

Ans: In terms of geography, the Americas led the global epilepsy therapeutic market and is likely to hold close to 50% of the revenue market shares.

Who are the main players in the Epilepsy Therapeutic Market report?

Ans: The main players in the Epilepsy Therapeutic Market are Abbott Laboratories, GlaxoSmithKline Plc, UCB, Cephalon, Johnson & Johnson, Pfizer, Novartis AG, Abbvie, Janssen Pharmaceuticals, Sunovion Pharmaceuticals, Bausch Health, Sanofi S.A, Takeda, Eisai, F. Hoffmann-La Roche

What are the Application segmentation covered in the Epilepsy Therapeutic Market report?

Ans: The Applications covered in the Epilepsy Therapeutic Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Epilepsy Therapeutic Market report?

Ans: The Types covered in the Epilepsy Therapeutic Market report are First Generation, Second Generation

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Epilepsy Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 First Generation

1.2.3 Second Generation

1.3 Market by Application

1.3.1 Global Epilepsy Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Epilepsy Therapeutic Market Perspective (2019-2030)

2.2 Epilepsy Therapeutic Growth Trends by Region

2.2.1 Global Epilepsy Therapeutic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Epilepsy Therapeutic Historic Market Size by Region (2019-2024)

2.2.3 Epilepsy Therapeutic Forecasted Market Size by Region (2025-2030)

2.3 Epilepsy Therapeutic Market Dynamics

2.3.1 Epilepsy Therapeutic Industry Trends

2.3.2 Epilepsy Therapeutic Market Drivers

2.3.3 Epilepsy Therapeutic Market Challenges

2.3.4 Epilepsy Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Epilepsy Therapeutic Players by Revenue

3.1.1 Global Top Epilepsy Therapeutic Players by Revenue (2019-2024)

3.1.2 Global Epilepsy Therapeutic Revenue Market Share by Players (2019-2024)

3.2 Global Epilepsy Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Epilepsy Therapeutic Revenue

3.4 Global Epilepsy Therapeutic Market Concentration Ratio

3.4.1 Global Epilepsy Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Therapeutic Revenue in 2023

3.5 Epilepsy Therapeutic Key Players Head office and Area Served

3.6 Key Players Epilepsy Therapeutic Product Solution and Service

3.7 Date of Enter into Epilepsy Therapeutic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Epilepsy Therapeutic Breakdown Data by Type

4.1 Global Epilepsy Therapeutic Historic Market Size by Type (2019-2024)

4.2 Global Epilepsy Therapeutic Forecasted Market Size by Type (2025-2030)

5 Epilepsy Therapeutic Breakdown Data by Application

5.1 Global Epilepsy Therapeutic Historic Market Size by Application (2019-2024)

5.2 Global Epilepsy Therapeutic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Epilepsy Therapeutic Market Size (2019-2030)

6.2 North America Epilepsy Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Epilepsy Therapeutic Market Size by Country (2019-2024)

6.4 North America Epilepsy Therapeutic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Epilepsy Therapeutic Market Size (2019-2030)

7.2 Europe Epilepsy Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Epilepsy Therapeutic Market Size by Country (2019-2024)

7.4 Europe Epilepsy Therapeutic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Epilepsy Therapeutic Market Size (2019-2030)

8.2 Asia-Pacific Epilepsy Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Epilepsy Therapeutic Market Size by Region (2019-2024)

8.4 Asia-Pacific Epilepsy Therapeutic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Epilepsy Therapeutic Market Size (2019-2030)

9.2 Latin America Epilepsy Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Epilepsy Therapeutic Market Size by Country (2019-2024)

9.4 Latin America Epilepsy Therapeutic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Epilepsy Therapeutic Market Size (2019-2030)

10.2 Middle East & Africa Epilepsy Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Epilepsy Therapeutic Market Size by Country (2019-2024)

10.4 Middle East & Africa Epilepsy Therapeutic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Epilepsy Therapeutic Introduction

11.1.4 Abbott Laboratories Revenue in Epilepsy Therapeutic Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 GlaxoSmithKline Plc

11.2.1 GlaxoSmithKline Plc Company Detail

11.2.2 GlaxoSmithKline Plc Business Overview

11.2.3 GlaxoSmithKline Plc Epilepsy Therapeutic Introduction

11.2.4 GlaxoSmithKline Plc Revenue in Epilepsy Therapeutic Business (2019-2024)

11.2.5 GlaxoSmithKline Plc Recent Development

11.3 UCB

11.3.1 UCB Company Detail

11.3.2 UCB Business Overview

11.3.3 UCB Epilepsy Therapeutic Introduction

11.3.4 UCB Revenue in Epilepsy Therapeutic Business (2019-2024)

11.3.5 UCB Recent Development

11.4 Cephalon

11.4.1 Cephalon Company Detail

11.4.2 Cephalon Business Overview

11.4.3 Cephalon Epilepsy Therapeutic Introduction

11.4.4 Cephalon Revenue in Epilepsy Therapeutic Business (2019-2024)

11.4.5 Cephalon Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Epilepsy Therapeutic Introduction

11.5.4 Johnson & Johnson Revenue in Epilepsy Therapeutic Business (2019-2024)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Epilepsy Therapeutic Introduction

11.6.4 Pfizer Revenue in Epilepsy Therapeutic Business (2019-2024)

11.6.5 Pfizer Recent Development

11.7 Novartis AG

11.7.1 Novartis AG Company Detail

11.7.2 Novartis AG Business Overview

11.7.3 Novartis AG Epilepsy Therapeutic Introduction

11.7.4 Novartis AG Revenue in Epilepsy Therapeutic Business (2019-2024)

11.7.5 Novartis AG Recent Development

11.8 Abbvie

11.8.1 Abbvie Company Detail

11.8.2 Abbvie Business Overview

11.8.3 Abbvie Epilepsy Therapeutic Introduction

11.8.4 Abbvie Revenue in Epilepsy Therapeutic Business (2019-2024)

11.8.5 Abbvie Recent Development

11.9 Janssen Pharmaceuticals

11.9.1 Janssen Pharmaceuticals Company Detail

11.9.2 Janssen Pharmaceuticals Business Overview

11.9.3 Janssen Pharmaceuticals Epilepsy Therapeutic Introduction

11.9.4 Janssen Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2019-2024)

11.9.5 Janssen Pharmaceuticals Recent Development

11.10 Sunovion Pharmaceuticals

11.10.1 Sunovion Pharmaceuticals Company Detail

11.10.2 Sunovion Pharmaceuticals Business Overview

11.10.3 Sunovion Pharmaceuticals Epilepsy Therapeutic Introduction

11.10.4 Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2019-2024)

11.10.5 Sunovion Pharmaceuticals Recent Development

11.11 Bausch Health

11.11.1 Bausch Health Company Detail

11.11.2 Bausch Health Business Overview

11.11.3 Bausch Health Epilepsy Therapeutic Introduction

11.11.4 Bausch Health Revenue in Epilepsy Therapeutic Business (2019-2024)

11.11.5 Bausch Health Recent Development

11.12 Sanofi S.A

11.12.1 Sanofi S.A Company Detail

11.12.2 Sanofi S.A Business Overview

11.12.3 Sanofi S.A Epilepsy Therapeutic Introduction

11.12.4 Sanofi S.A Revenue in Epilepsy Therapeutic Business (2019-2024)

11.12.5 Sanofi S.A Recent Development

11.13 Takeda

11.13.1 Takeda Company Detail

11.13.2 Takeda Business Overview

11.13.3 Takeda Epilepsy Therapeutic Introduction

11.13.4 Takeda Revenue in Epilepsy Therapeutic Business (2019-2024)

11.13.5 Takeda Recent Development

11.14 Eisai

11.14.1 Eisai Company Detail

11.14.2 Eisai Business Overview

11.14.3 Eisai Epilepsy Therapeutic Introduction

11.14.4 Eisai Revenue in Epilepsy Therapeutic Business (2019-2024)

11.14.5 Eisai Recent Development

11.15 F. Hoffmann-La Roche

11.15.1 F. Hoffmann-La Roche Company Detail

11.15.2 F. Hoffmann-La Roche Business Overview

11.15.3 F. Hoffmann-La Roche Epilepsy Therapeutic Introduction

11.15.4 F. Hoffmann-La Roche Revenue in Epilepsy Therapeutic Business (2019-2024)

11.15.5 F. Hoffmann-La Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Janssen Pharmaceuticals

Sunovion Pharmaceuticals

List of Tables

Table 1. Global Epilepsy Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of First Generation

Table 3. Key Players of Second Generation

Table 4. Global Epilepsy Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Epilepsy Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Epilepsy Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Epilepsy Therapeutic Market Share by Region (2019-2024)

Table 8. Global Epilepsy Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Epilepsy Therapeutic Market Share by Region (2025-2030)

Table 10. Epilepsy Therapeutic Market Trends

Table 11. Epilepsy Therapeutic Market Drivers

Table 12. Epilepsy Therapeutic Market Challenges

Table 13. Epilepsy Therapeutic Market Restraints

Table 14. Global Epilepsy Therapeutic Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Epilepsy Therapeutic Market Share by Players (2019-2024)

Table 16. Global Top Epilepsy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Therapeutic as of 2023)

Table 17. Ranking of Global Top Epilepsy Therapeutic Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Epilepsy Therapeutic Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Epilepsy Therapeutic Product Solution and Service

Table 21. Date of Enter into Epilepsy Therapeutic Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Epilepsy Therapeutic Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Epilepsy Therapeutic Revenue Market Share by Type (2019-2024)

Table 25. Global Epilepsy Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Epilepsy Therapeutic Revenue Market Share by Type (2025-2030)

Table 27. Global Epilepsy Therapeutic Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Epilepsy Therapeutic Revenue Market Share by Application (2019-2024)

Table 29. Global Epilepsy Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Epilepsy Therapeutic Revenue Market Share by Application (2025-2030)

Table 31. North America Epilepsy Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Epilepsy Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Epilepsy Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Epilepsy Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Epilepsy Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Epilepsy Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Epilepsy Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Epilepsy Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Epilepsy Therapeutic Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Epilepsy Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Epilepsy Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Epilepsy Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Epilepsy Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Epilepsy Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Epilepsy Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 46. Abbott Laboratories Company Detail

Table 47. Abbott Laboratories Business Overview

Table 48. Abbott Laboratories Epilepsy Therapeutic Product

Table 49. Abbott Laboratories Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 50. Abbott Laboratories Recent Development

Table 51. GlaxoSmithKline Plc Company Detail

Table 52. GlaxoSmithKline Plc Business Overview

Table 53. GlaxoSmithKline Plc Epilepsy Therapeutic Product

Table 54. GlaxoSmithKline Plc Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 55. GlaxoSmithKline Plc Recent Development

Table 56. UCB Company Detail

Table 57. UCB Business Overview

Table 58. UCB Epilepsy Therapeutic Product

Table 59. UCB Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 60. UCB Recent Development

Table 61. Cephalon Company Detail

Table 62. Cephalon Business Overview

Table 63. Cephalon Epilepsy Therapeutic Product

Table 64. Cephalon Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 65. Cephalon Recent Development

Table 66. Johnson & Johnson Company Detail

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Epilepsy Therapeutic Product

Table 69. Johnson & Johnson Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Pfizer Company Detail

Table 72. Pfizer Business Overview

Table 73. Pfizer Epilepsy Therapeutic Product

Table 74. Pfizer Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Novartis AG Company Detail

Table 77. Novartis AG Business Overview

Table 78. Novartis AG Epilepsy Therapeutic Product

Table 79. Novartis AG Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 80. Novartis AG Recent Development

Table 81. Abbvie Company Detail

Table 82. Abbvie Business Overview

Table 83. Abbvie Epilepsy Therapeutic Product

Table 84. Abbvie Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 85. Abbvie Recent Development

Table 86. Janssen Pharmaceuticals Company Detail

Table 87. Janssen Pharmaceuticals Business Overview

Table 88. Janssen Pharmaceuticals Epilepsy Therapeutic Product

Table 89. Janssen Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 90. Janssen Pharmaceuticals Recent Development

Table 91. Sunovion Pharmaceuticals Company Detail

Table 92. Sunovion Pharmaceuticals Business Overview

Table 93. Sunovion Pharmaceuticals Epilepsy Therapeutic Product

Table 94. Sunovion Pharmaceuticals Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 95. Sunovion Pharmaceuticals Recent Development

Table 96. Bausch Health Company Detail

Table 97. Bausch Health Business Overview

Table 98. Bausch Health Epilepsy Therapeutic Product

Table 99. Bausch Health Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 100. Bausch Health Recent Development

Table 101. Sanofi S.A Company Detail

Table 102. Sanofi S.A Business Overview

Table 103. Sanofi S.A Epilepsy Therapeutic Product

Table 104. Sanofi S.A Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 105. Sanofi S.A Recent Development

Table 106. Takeda Company Detail

Table 107. Takeda Business Overview

Table 108. Takeda Epilepsy Therapeutic Product

Table 109. Takeda Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 110. Takeda Recent Development

Table 111. Eisai Company Detail

Table 112. Eisai Business Overview

Table 113. Eisai Epilepsy Therapeutic Product

Table 114. Eisai Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 115. Eisai Recent Development

Table 116. F. Hoffmann-La Roche Company Detail

Table 117. F. Hoffmann-La Roche Business Overview

Table 118. F. Hoffmann-La Roche Epilepsy Therapeutic Product

Table 119. F. Hoffmann-La Roche Revenue in Epilepsy Therapeutic Business (2019-2024) & (US$ Million)

Table 120. F. Hoffmann-La Roche Recent Development

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Epilepsy Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Epilepsy Therapeutic Market Share by Type: 2023 VS 2030

Figure 3. First Generation Features

Figure 4. Second Generation Features

Figure 5. Global Epilepsy Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Epilepsy Therapeutic Market Share by Application: 2023 VS 2030

Figure 7. Hospital Pharmacies Case Studies

Figure 8. Retail Pharmacies Case Studies

Figure 9. Online Pharmacies Case Studies

Figure 10. Epilepsy Therapeutic Report Years Considered

Figure 11. Global Epilepsy Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Epilepsy Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Epilepsy Therapeutic Market Share by Region: 2023 VS 2030

Figure 14. Global Epilepsy Therapeutic Market Share by Players in 2023

Figure 15. Global Top Epilepsy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy Therapeutic as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Epilepsy Therapeutic Revenue in 2023

Figure 17. North America Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Epilepsy Therapeutic Market Share by Country (2019-2030)

Figure 19. United States Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Epilepsy Therapeutic Market Share by Country (2019-2030)

Figure 23. Germany Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Epilepsy Therapeutic Market Share by Region (2019-2030)

Figure 31. China Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Epilepsy Therapeutic Market Share by Country (2019-2030)

Figure 39. Mexico Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Epilepsy Therapeutic Market Share by Country (2019-2030)

Figure 43. Turkey Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Epilepsy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Abbott Laboratories Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 46. GlaxoSmithKline Plc Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 47. UCB Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 48. Cephalon Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 49. Johnson & Johnson Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 50. Pfizer Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 51. Novartis AG Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 52. Abbvie Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 53. Janssen Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 54. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 55. Bausch Health Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 56. Sanofi S.A Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 57. Takeda Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 58. Eisai Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Epilepsy Therapeutic Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cerebral Palsy Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36K2790

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Chorea Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-22U5801

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Autism Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29P12566

Mon Mar 25 00:00:00 UTC 2024

Add to Cart

Spinal Cord Stimulation Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11Z11048

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions